CASI Pharmaceuticals
Rockville · Founded 1991
About CASI Pharmaceuticals
CASI Pharmaceuticals, Inc. ("CASI", "we" or "us") is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. CASI is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. CASI is executing its plan to become a biopharmaceutical leader by launching medicines in the greater China market leveraging CASI's China-based regulatory and commercial competencies and its global drug development expertise.
Company Facts
- Founded: 1991
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $220.4M
- Funding stage: IPO
- Last round: Post-IPO Debt (Dec 2025)
- Ticker: nasdaq:CASI
- Website: casipharmaceuticals.com
- Phone: (240) 864-2643
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/casi-pharmaceuticals-19937 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.